 | • レポートコード：MRC2-11QY11901 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は体外血液治療のグローバル市場について調査・分析したレポートです。種類別（血液透析、急性透析、アフェレーシス）市場規模、用途別（重症敗血症、急性肺損傷、肝不全、心原性ショック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別体外血液治療の競争状況、市場シェア ・世界の体外血液治療市場：種類別市場規模 2015年-2020年（血液透析、急性透析、アフェレーシス） ・世界の体外血液治療市場：種類別市場規模予測 2021年-2026年（血液透析、急性透析、アフェレーシス） ・世界の体外血液治療市場：用途別市場規模 2015年-2020年（重症敗血症、急性肺損傷、肝不全、心原性ショック） ・世界の体外血液治療市場：用途別市場規模予測 2021年-2026年（重症敗血症、急性肺損傷、肝不全、心原性ショック） ・北米の体外血液治療市場分析：米国、カナダ ・ヨーロッパの体外血液治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの体外血液治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の体外血液治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの体外血液治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Fresenius Medical Care、DaVita Kidney Care、Renal Care、Dialysis Clinic、American Renal Associates、Satellite Healthcare、Atlantic Dialysis Management、Northwest Kidney Centers、Centers for Dialyssis Care、Rogosin Institute、B. Braun ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
The extracorporeal blood treatment is a type of filtration method used to remove many toxins from the blood.
The demand for extracorporeal blood treatment is expected to upsurge owing to the growth of kidney diseases.
Market Analysis and Insights: Global Extracorporeal Blood Treatment Market
The global Extracorporeal Blood Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Extracorporeal Blood Treatment Scope and Market Size
Extracorporeal Blood Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Extracorporeal Blood Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Fresenius Medical Care
DaVita Kidney Care
Renal Care
Dialysis Clinic
American Renal Associates
Satellite Healthcare
Atlantic Dialysis Management
Northwest Kidney Centers
Centers for Dialyssis Care
Rogosin Institute
B. Braun
Market segment by Type, the product can be split into
Hemodialysis
Acute dialysis
Apheresis
Market segment by Application, split into
Severe Sepsis
Acute Lung Injury
Liver Failure
Cardiogenic Shock
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Extracorporeal Blood Treatment Revenue
1.4 Market by Type
1.4.1 Global Extracorporeal Blood Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Hemodialysis
1.4.3 Acute dialysis
1.4.4 Apheresis
1.5 Market by Application
1.5.1 Global Extracorporeal Blood Treatment Market Share by Application: 2020 VS 2026
1.5.2 Severe Sepsis
1.5.3 Acute Lung Injury
1.5.4 Liver Failure
1.5.5 Cardiogenic Shock
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Extracorporeal Blood Treatment Market Perspective (2015-2026)
2.2 Global Extracorporeal Blood Treatment Growth Trends by Regions
2.2.1 Extracorporeal Blood Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Extracorporeal Blood Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Extracorporeal Blood Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Extracorporeal Blood Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Extracorporeal Blood Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Extracorporeal Blood Treatment Players by Market Size
3.1.1 Global Top Extracorporeal Blood Treatment Players by Revenue (2015-2020)
3.1.2 Global Extracorporeal Blood Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Extracorporeal Blood Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Extracorporeal Blood Treatment Market Concentration Ratio
3.2.1 Global Extracorporeal Blood Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Extracorporeal Blood Treatment Revenue in 2019
3.3 Extracorporeal Blood Treatment Key Players Head office and Area Served
3.4 Key Players Extracorporeal Blood Treatment Product Solution and Service
3.5 Date of Enter into Extracorporeal Blood Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Extracorporeal Blood Treatment Historic Market Size by Type (2015-2020)
4.2 Global Extracorporeal Blood Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Extracorporeal Blood Treatment Market Size by Application (2015-2020)
5.2 Global Extracorporeal Blood Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Extracorporeal Blood Treatment Market Size (2015-2020)
6.2 Extracorporeal Blood Treatment Key Players in North America (2019-2020)
6.3 North America Extracorporeal Blood Treatment Market Size by Type (2015-2020)
6.4 North America Extracorporeal Blood Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Extracorporeal Blood Treatment Market Size (2015-2020)
7.2 Extracorporeal Blood Treatment Key Players in Europe (2019-2020)
7.3 Europe Extracorporeal Blood Treatment Market Size by Type (2015-2020)
7.4 Europe Extracorporeal Blood Treatment Market Size by Application (2015-2020)
8 China
8.1 China Extracorporeal Blood Treatment Market Size (2015-2020)
8.2 Extracorporeal Blood Treatment Key Players in China (2019-2020)
8.3 China Extracorporeal Blood Treatment Market Size by Type (2015-2020)
8.4 China Extracorporeal Blood Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Extracorporeal Blood Treatment Market Size (2015-2020)
9.2 Extracorporeal Blood Treatment Key Players in Japan (2019-2020)
9.3 Japan Extracorporeal Blood Treatment Market Size by Type (2015-2020)
9.4 Japan Extracorporeal Blood Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Extracorporeal Blood Treatment Market Size (2015-2020)
10.2 Extracorporeal Blood Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Extracorporeal Blood Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Extracorporeal Blood Treatment Market Size by Application (2015-2020)
11 India
11.1 India Extracorporeal Blood Treatment Market Size (2015-2020)
11.2 Extracorporeal Blood Treatment Key Players in India (2019-2020)
11.3 India Extracorporeal Blood Treatment Market Size by Type (2015-2020)
11.4 India Extracorporeal Blood Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Extracorporeal Blood Treatment Market Size (2015-2020)
12.2 Extracorporeal Blood Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Extracorporeal Blood Treatment Market Size by Type (2015-2020)
12.4 Central & South America Extracorporeal Blood Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Fresenius Medical Care
13.1.1 Fresenius Medical Care Company Details
13.1.2 Fresenius Medical Care Business Overview
13.1.3 Fresenius Medical Care Extracorporeal Blood Treatment Introduction
13.1.4 Fresenius Medical Care Revenue in Extracorporeal Blood Treatment Business (2015-2020))
13.1.5 Fresenius Medical Care Recent Development
13.2 DaVita Kidney Care
13.2.1 DaVita Kidney Care Company Details
13.2.2 DaVita Kidney Care Business Overview
13.2.3 DaVita Kidney Care Extracorporeal Blood Treatment Introduction
13.2.4 DaVita Kidney Care Revenue in Extracorporeal Blood Treatment Business (2015-2020)
13.2.5 DaVita Kidney Care Recent Development
13.3 Renal Care
13.3.1 Renal Care Company Details
13.3.2 Renal Care Business Overview
13.3.3 Renal Care Extracorporeal Blood Treatment Introduction
13.3.4 Renal Care Revenue in Extracorporeal Blood Treatment Business (2015-2020)
13.3.5 Renal Care Recent Development
13.4 Dialysis Clinic
13.4.1 Dialysis Clinic Company Details
13.4.2 Dialysis Clinic Business Overview
13.4.3 Dialysis Clinic Extracorporeal Blood Treatment Introduction
13.4.4 Dialysis Clinic Revenue in Extracorporeal Blood Treatment Business (2015-2020)
13.4.5 Dialysis Clinic Recent Development
13.5 American Renal Associates
13.5.1 American Renal Associates Company Details
13.5.2 American Renal Associates Business Overview
13.5.3 American Renal Associates Extracorporeal Blood Treatment Introduction
13.5.4 American Renal Associates Revenue in Extracorporeal Blood Treatment Business (2015-2020)
13.5.5 American Renal Associates Recent Development
13.6 Satellite Healthcare
13.6.1 Satellite Healthcare Company Details
13.6.2 Satellite Healthcare Business Overview
13.6.3 Satellite Healthcare Extracorporeal Blood Treatment Introduction
13.6.4 Satellite Healthcare Revenue in Extracorporeal Blood Treatment Business (2015-2020)
13.6.5 Satellite Healthcare Recent Development
13.7 Atlantic Dialysis Management
13.7.1 Atlantic Dialysis Management Company Details
13.7.2 Atlantic Dialysis Management Business Overview
13.7.3 Atlantic Dialysis Management Extracorporeal Blood Treatment Introduction
13.7.4 Atlantic Dialysis Management Revenue in Extracorporeal Blood Treatment Business (2015-2020)
13.7.5 Atlantic Dialysis Management Recent Development
13.8 Northwest Kidney Centers
13.8.1 Northwest Kidney Centers Company Details
13.8.2 Northwest Kidney Centers Business Overview
13.8.3 Northwest Kidney Centers Extracorporeal Blood Treatment Introduction
13.8.4 Northwest Kidney Centers Revenue in Extracorporeal Blood Treatment Business (2015-2020)
13.8.5 Northwest Kidney Centers Recent Development
13.9 Centers for Dialyssis Care
13.9.1 Centers for Dialyssis Care Company Details
13.9.2 Centers for Dialyssis Care Business Overview
13.9.3 Centers for Dialyssis Care Extracorporeal Blood Treatment Introduction
13.9.4 Centers for Dialyssis Care Revenue in Extracorporeal Blood Treatment Business (2015-2020)
13.9.5 Centers for Dialyssis Care Recent Development
13.10 Rogosin Institute
13.10.1 Rogosin Institute Company Details
13.10.2 Rogosin Institute Business Overview
13.10.3 Rogosin Institute Extracorporeal Blood Treatment Introduction
13.10.4 Rogosin Institute Revenue in Extracorporeal Blood Treatment Business (2015-2020)
13.10.5 Rogosin Institute Recent Development
13.11 B. Braun
10.11.1 B. Braun Company Details
10.11.2 B. Braun Business Overview
10.11.3 B. Braun Extracorporeal Blood Treatment Introduction
10.11.4 B. Braun Revenue in Extracorporeal Blood Treatment Business (2015-2020)
10.11.5 B. Braun Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Extracorporeal Blood Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Extracorporeal Blood Treatment Revenue
Table 3. Ranking of Global Top Extracorporeal Blood Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Extracorporeal Blood Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Hemodialysis
Table 6. Key Players of Acute dialysis
Table 7. Key Players of Apheresis
Table 8. Global Extracorporeal Blood Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Extracorporeal Blood Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Extracorporeal Blood Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Extracorporeal Blood Treatment Market Share by Regions (2015-2020)
Table 12. Global Extracorporeal Blood Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Extracorporeal Blood Treatment Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Extracorporeal Blood Treatment Market Growth Strategy
Table 18. Main Points Interviewed from Key Extracorporeal Blood Treatment Players
Table 19. Global Extracorporeal Blood Treatment Revenue by Players (2015-2020) (Million US$)
Table 20. Global Extracorporeal Blood Treatment Market Share by Players (2015-2020)
Table 21. Global Top Extracorporeal Blood Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Extracorporeal Blood Treatment as of 2019)
Table 22. Global Extracorporeal Blood Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Extracorporeal Blood Treatment Product Solution and Service
Table 25. Date of Enter into Extracorporeal Blood Treatment Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Extracorporeal Blood Treatment Market Size by Type (2015-2020) (Million US$)
Table 28. Global Extracorporeal Blood Treatment Market Size Share by Type (2015-2020)
Table 29. Global Extracorporeal Blood Treatment Revenue Market Share by Type (2021-2026)
Table 30. Global Extracorporeal Blood Treatment Market Size Share by Application (2015-2020)
Table 31. Global Extracorporeal Blood Treatment Market Size by Application (2015-2020) (Million US$)
Table 32. Global Extracorporeal Blood Treatment Market Size Share by Application (2021-2026)
Table 33. North America Key Players Extracorporeal Blood Treatment Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Extracorporeal Blood Treatment Market Share (2019-2020)
Table 35. North America Extracorporeal Blood Treatment Market Size by Type (2015-2020) (Million US$)
Table 36. North America Extracorporeal Blood Treatment Market Share by Type (2015-2020)
Table 37. North America Extracorporeal Blood Treatment Market Size by Application (2015-2020) (Million US$)
Table 38. North America Extracorporeal Blood Treatment Market Share by Application (2015-2020)
Table 39. Europe Key Players Extracorporeal Blood Treatment Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Extracorporeal Blood Treatment Market Share (2019-2020)
Table 41. Europe Extracorporeal Blood Treatment Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Extracorporeal Blood Treatment Market Share by Type (2015-2020)
Table 43. Europe Extracorporeal Blood Treatment Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Extracorporeal Blood Treatment Market Share by Application (2015-2020)
Table 45. China Key Players Extracorporeal Blood Treatment Revenue (2019-2020) (Million US$)
Table 46. China Key Players Extracorporeal Blood Treatment Market Share (2019-2020)
Table 47. China Extracorporeal Blood Treatment Market Size by Type (2015-2020) (Million US$)
Table 48. China Extracorporeal Blood Treatment Market Share by Type (2015-2020)
Table 49. China Extracorporeal Blood Treatment Market Size by Application (2015-2020) (Million US$)
Table 50. China Extracorporeal Blood Treatment Market Share by Application (2015-2020)
Table 51. Japan Key Players Extracorporeal Blood Treatment Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Extracorporeal Blood Treatment Market Share (2019-2020)
Table 53. Japan Extracorporeal Blood Treatment Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Extracorporeal Blood Treatment Market Share by Type (2015-2020)
Table 55. Japan Extracorporeal Blood Treatment Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Extracorporeal Blood Treatment Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Extracorporeal Blood Treatment Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Extracorporeal Blood Treatment Market Share (2019-2020)
Table 59. Southeast Asia Extracorporeal Blood Treatment Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Extracorporeal Blood Treatment Market Share by Type (2015-2020)
Table 61. Southeast Asia Extracorporeal Blood Treatment Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Extracorporeal Blood Treatment Market Share by Application (2015-2020)
Table 63. India Key Players Extracorporeal Blood Treatment Revenue (2019-2020) (Million US$)
Table 64. India Key Players Extracorporeal Blood Treatment Market Share (2019-2020)
Table 65. India Extracorporeal Blood Treatment Market Size by Type (2015-2020) (Million US$)
Table 66. India Extracorporeal Blood Treatment Market Share by Type (2015-2020)
Table 67. India Extracorporeal Blood Treatment Market Size by Application (2015-2020) (Million US$)
Table 68. India Extracorporeal Blood Treatment Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Extracorporeal Blood Treatment Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Extracorporeal Blood Treatment Market Share (2019-2020)
Table 71. Central & South America Extracorporeal Blood Treatment Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Extracorporeal Blood Treatment Market Share by Type (2015-2020)
Table 73. Central & South America Extracorporeal Blood Treatment Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Extracorporeal Blood Treatment Market Share by Application (2015-2020)
Table 75. Fresenius Medical Care Company Details
Table 76. Fresenius Medical Care Business Overview
Table 77. Fresenius Medical Care Product
Table 78. Fresenius Medical Care Revenue in Extracorporeal Blood Treatment Business (2015-2020) (Million US$)
Table 79. Fresenius Medical Care Recent Development
Table 80. DaVita Kidney Care Company Details
Table 81. DaVita Kidney Care Business Overview
Table 82. DaVita Kidney Care Product
Table 83. DaVita Kidney Care Revenue in Extracorporeal Blood Treatment Business (2015-2020) (Million US$)
Table 84. DaVita Kidney Care Recent Development
Table 85. Renal Care Company Details
Table 86. Renal Care Business Overview
Table 87. Renal Care Product
Table 88. Renal Care Revenue in Extracorporeal Blood Treatment Business (2015-2020) (Million US$)
Table 89. Renal Care Recent Development
Table 90. Dialysis Clinic Company Details
Table 91. Dialysis Clinic Business Overview
Table 92. Dialysis Clinic Product
Table 93. Dialysis Clinic Revenue in Extracorporeal Blood Treatment Business (2015-2020) (Million US$)
Table 94. Dialysis Clinic Recent Development
Table 95. American Renal Associates Company Details
Table 96. American Renal Associates Business Overview
Table 97. American Renal Associates Product
Table 98. American Renal Associates Revenue in Extracorporeal Blood Treatment Business (2015-2020) (Million US$)
Table 99. American Renal Associates Recent Development
Table 100. Satellite Healthcare Company Details
Table 101. Satellite Healthcare Business Overview
Table 102. Satellite Healthcare Product
Table 103. Satellite Healthcare Revenue in Extracorporeal Blood Treatment Business (2015-2020) (Million US$)
Table 104. Satellite Healthcare Recent Development
Table 105. Atlantic Dialysis Management Company Details
Table 106. Atlantic Dialysis Management Business Overview
Table 107. Atlantic Dialysis Management Product
Table 108. Atlantic Dialysis Management Revenue in Extracorporeal Blood Treatment Business (2015-2020) (Million US$)
Table 109. Atlantic Dialysis Management Recent Development
Table 110. Northwest Kidney Centers Business Overview
Table 111. Northwest Kidney Centers Product
Table 112. Northwest Kidney Centers Company Details
Table 113. Northwest Kidney Centers Revenue in Extracorporeal Blood Treatment Business (2015-2020) (Million US$)
Table 114. Northwest Kidney Centers Recent Development
Table 115. Centers for Dialyssis Care Company Details
Table 116. Centers for Dialyssis Care Business Overview
Table 117. Centers for Dialyssis Care Product
Table 118. Centers for Dialyssis Care Revenue in Extracorporeal Blood Treatment Business (2015-2020) (Million US$)
Table 119. Centers for Dialyssis Care Recent Development
Table 120. Rogosin Institute Company Details
Table 121. Rogosin Institute Business Overview
Table 122. Rogosin Institute Product
Table 123. Rogosin Institute Revenue in Extracorporeal Blood Treatment Business (2015-2020) (Million US$)
Table 124. Rogosin Institute Recent Development
Table 125. B. Braun Company Details
Table 126. B. Braun Business Overview
Table 127. B. Braun Product
Table 128. B. Braun Revenue in Extracorporeal Blood Treatment Business (2015-2020) (Million US$)
Table 129. B. Braun Recent Development
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Extracorporeal Blood Treatment Market Share by Type: 2020 VS 2026
Figure 2. Hemodialysis Features
Figure 3. Acute dialysis Features
Figure 4. Apheresis Features
Figure 5. Global Extracorporeal Blood Treatment Market Share by Application: 2020 VS 2026
Figure 6. Severe Sepsis Case Studies
Figure 7. Acute Lung Injury Case Studies
Figure 8. Liver Failure Case Studies
Figure 9. Cardiogenic Shock Case Studies
Figure 10. Extracorporeal Blood Treatment Report Years Considered
Figure 11. Global Extracorporeal Blood Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Extracorporeal Blood Treatment Market Share by Regions: 2020 VS 2026
Figure 13. Global Extracorporeal Blood Treatment Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Extracorporeal Blood Treatment Market Share by Players in 2019
Figure 16. Global Top Extracorporeal Blood Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Extracorporeal Blood Treatment as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Extracorporeal Blood Treatment Revenue in 2019
Figure 18. North America Extracorporeal Blood Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Extracorporeal Blood Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Extracorporeal Blood Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Extracorporeal Blood Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Extracorporeal Blood Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Extracorporeal Blood Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Extracorporeal Blood Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
体外衝撃波結石破砕術（ESWL）の世界市場（～2026年） Market Analysis and Insights: Global Extracorporeal Shock-wave Lithotripsy (ESWL) Market The global Extracorporeal Shock-wave Lithotripsy (ESWL) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Extracorporeal Shock-wave…- 体外式膜型人工肺（ECMO）の世界市場（～2026年） ECMO is an extracorporeal technique of providing prolonged cardiac and respiratory support to persons whose heart and lungs are unable to provide an adequate amount of gas exchange or perfusion to sustain life The major factors boosting growth are the rising incidences of Chronic Obstructive Pulmona…
- 急性感音難聴治療の世界市場（～2026年） Acute Sensorineural hearing loss is also known as sudden hearing loss involves an acute unexplained sensorineural hearing loss. Acute Sensorineural hearing loss hearing loss is defined as more than 30 dB hearing decline, over at least three contiguous frequencies, occurring over a period of 72 hours…
- 急性腎不全治療薬の世界市場（～2026年） Acute renal failure is a sudden loss of kidney’s ability to eliminate excess fluids, salts and metabolic waste from the body. It leads to accumulation of metabolic waste and electrolytes in the body which can be life-threatening. Kidney eliminates creatinine (Metabolic waste) from the body. Acute re…
- 急性脊髄損傷の世界市場（～2026年） Acute spinal cord injury (SCI) is a clinical condition caused due to a painful injury that result in a contusion or bruise to a fractional or complete spinal cord resulting into permanent disability and/or death in adults and children. The treatment of acute spinal cord injury is dependent on few f…